Emmecell receives FDA RMAT designation for EO2002, advancing development of its regenerative cell therapy for corneal ...
In a recent review published in Life, researchers discussed the pathophysiological mechanisms of endothelial dysfunction associated with severe coronavirus disease 2019 (COVID-19). They commented on ...
A polygenic risk score (PRS) based on genes associated with endothelial cell function identifies patients at a higher risk of coronary artery disease, according to a new study. The risk score, which ...
The FDA granted regenerative medicine advanced therapy designation to EO2002 for the treatment of corneal edema secondary to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results